Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity

References

• Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J 2011;58:237–246.
   PubMed Web of Science ®Google Scholar
• Marshall JC, Dalkin A, Haisenleder DY. Gonadotropin releasing hormone puls: Regulators of gonadotropin synthesis and ovulatory cycles. Revent Prog Horm Res 1991;47: 155.
   Google Scholar
• Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, Janssen OE. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2007;115:130–135.
   PubMed Web of Science ®Google Scholar
• Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, Guzick DS, Hoeger KM. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:4780–4786.
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579–1585.
   PubMed Web of Science ®Google Scholar
• Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008;37:635–646, viii–ix.
   PubMed Web of Science ®Google Scholar
• Guo Z, Hensrud DD, Johnson CM, Jensen MD. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999;48:1586–1592.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25.
   Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Pugeat M, Ducluzeau PH. Insulin resistance, polycystic ovary syndrome and metformin. Drugs 1999;58 Suppl 1:41–6; discussion 75.
   PubMed Web of Science ®Google Scholar
• Wehr E, Möller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N, Groselj-Strele A, et al. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wien Klin Wochenschr 2009;121:262–269.
   PubMed Web of Science ®Google Scholar
• Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments and visceral adipose tissue in the metabolic components of obesity. Metabolism 2001;50:425–435.
   PubMed Web of Science ®Google Scholar
• dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women. Gynecol Endocrinol 2005;21:295–301.
   PubMed Web of Science ®Google Scholar
• Capkova-Parizkova J. Measurement of subcutaneous fat by a caliper. Cesk Pediatr 1958;13:310–311.
   PubMedGoogle Scholar
• Ludescher B, Machann J, Eschweiler GW, Vanhöfen S, Maenz C, Thamer C, Claussen CD, Schick F. Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol 2009;44:712–719.
   PubMed Web of Science ®Google Scholar
• Ng J, Rohling R, Lawrence PD. Automatic measurement of human subcutaneous fat with ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control 2009;56:1642–1653.
   PubMed Web of Science ®Google Scholar
• Eston RG, Rowlands AV, Charlesworth S, Davies A, Hoppitt T. Prediction of DXA-determined whole body fat from skinfolds: importance of including skinfolds from the thigh and calf in young, healthy men and women. Eur J Clin Nutr 2005;59:695–702.
   PubMed Web of Science ®Google Scholar
• Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Bas O. Body fat composition and distribution in women with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:428–432.
   PubMed Web of Science ®Google Scholar
• Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K, Andersen M. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009;94:4010–4015.
   PubMed Web of Science ®Google Scholar
• Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 2010;17:4511–4520.
   PubMed Web of Science ®Google Scholar
• Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, Boscaro M. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 2004;27:424–429.
   PubMed Web of Science ®Google Scholar
• Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol 2001;98:445–449.
   PubMed Web of Science ®Google Scholar
• Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 2009;161:583–589.
   PubMed Web of Science ®Google Scholar